Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

A non-canonical ESCRT pathway, including histidine domain phosphotyrosine phosphatase (HD-PTP), is used for down-regulation of virally ubiquitinated MHC class I.

Parkinson MD, Piper SC, Bright NA, Evans JL, Boname JM, Bowers K, Lehner PJ, Luzio JP.

Biochem J. 2015 Oct 1;471(1):79-88. doi: 10.1042/BJ20150336. Epub 2015 Jul 28.

2.

Cleavage by signal peptide peptidase is required for the degradation of selected tail-anchored proteins.

Boname JM, Bloor S, Wandel MP, Nathan JA, Antrobus R, Dingwell KS, Thurston TL, Smith DL, Smith JC, Randow F, Lehner PJ.

J Cell Biol. 2014 Jun 23;205(6):847-62. doi: 10.1083/jcb.201312009.

3.

Tapasin-related protein TAPBPR is an additional component of the MHC class I presentation pathway.

Boyle LH, Hermann C, Boname JM, Porter KM, Patel PA, Burr ML, Duncan LM, Harbour ME, Rhodes DA, Skjødt K, Lehner PJ, Trowsdale J.

Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3465-70. doi: 10.1073/pnas.1222342110. Epub 2013 Feb 11.

4.

Studying ubiquitination of MHC class I molecules.

Burr ML, Boname JM, Lehner PJ.

Methods Mol Biol. 2013;960:109-125. doi: 10.1007/978-1-62703-218-6_9.

PMID:
23329482
5.

What has the study of the K3 and K5 viral ubiquitin E3 ligases taught us about ubiquitin-mediated receptor regulation?

Boname JM, Lehner PJ.

Viruses. 2011 Feb;3(2):118-31. doi: 10.3390/v3020118. Epub 2011 Jan 28. Review.

6.

HRD1 and UBE2J1 target misfolded MHC class I heavy chains for endoplasmic reticulum-associated degradation.

Burr ML, Cano F, Svobodova S, Boyle LH, Boname JM, Lehner PJ.

Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):2034-9. doi: 10.1073/pnas.1016229108. Epub 2011 Jan 18.

7.

Identification of a lysosomal pathway regulating degradation of the bone morphogenetic protein receptor type II.

Durrington HJ, Upton PD, Hoer S, Boname J, Dunmore BJ, Yang J, Crilley TK, Butler LM, Blackbourn DJ, Nash GB, Lehner PJ, Morrell NW.

J Biol Chem. 2010 Nov 26;285(48):37641-9. doi: 10.1074/jbc.M110.132415. Epub 2010 Sep 24.

8.

Ubiquitination of lysine-331 by Kaposi's sarcoma-associated herpesvirus protein K5 targets HFE for lysosomal degradation.

Rhodes DA, Boyle LH, Boname JM, Lehner PJ, Trowsdale J.

Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16240-5. doi: 10.1073/pnas.1003421107. Epub 2010 Aug 30.

9.

Efficient internalization of MHC I requires lysine-11 and lysine-63 mixed linkage polyubiquitin chains.

Boname JM, Thomas M, Stagg HR, Xu P, Peng J, Lehner PJ.

Traffic. 2010 Feb;11(2):210-20. doi: 10.1111/j.1600-0854.2009.01011.x. Epub 2009 Nov 17.

10.

Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity.

Thomas M, Boname JM, Field S, Nejentsev S, Salio M, Cerundolo V, Wills M, Lehner PJ.

Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1656-61. doi: 10.1073/pnas.0707883105. Epub 2008 Jan 29.

11.

Dendritic cell stimulation by mycobacterial Hsp70 is mediated through CCR5.

Floto RA, MacAry PA, Boname JM, Mien TS, Kampmann B, Hair JR, Huey OS, Houben EN, Pieters J, Day C, Oehlmann W, Singh M, Smith KG, Lehner PJ.

Science. 2006 Oct 20;314(5798):454-8.

12.

Murine gammaherpesvirus-68 ORF28 encodes a non-essential virion glycoprotein.

May JS, Coleman HM, Boname JM, Stevenson PG.

J Gen Virol. 2005 Apr;86(Pt 4):919-28.

PMID:
15784886
13.
14.
15.

Viral degradation of the MHC class I peptide loading complex.

Boname JM, de Lima BD, Lehner PJ, Stevenson PG.

Immunity. 2004 Mar;20(3):305-17.

16.

Protection against wild-type murine gammaherpesvirus-68 latency by a latency-deficient mutant.

Boname JM, Coleman HM, May JS, Stevenson PG.

J Gen Virol. 2004 Jan;85(Pt 1):131-5.

PMID:
14718627
17.
18.

A battle for survival: immune control and immune evasion in murine gamma-herpesvirus-68 infection.

Stevenson PG, Boname JM, de Lima B, Efstathiou S.

Microbes Infect. 2002 Sep;4(11):1177-82. Review.

PMID:
12361918
19.
20.

MHC class I ubiquitination by a viral PHD/LAP finger protein.

Boname JM, Stevenson PG.

Immunity. 2001 Oct;15(4):627-36.

22.

Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells.

Tomazin R, Boname J, Hegde NR, Lewinsohn DM, Altschuler Y, Jones TR, Cresswell P, Nelson JA, Riddell SR, Johnson DC.

Nat Med. 1999 Sep;5(9):1039-43.

PMID:
10470081
23.

Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus.

Reichenspurner H, Soni V, Nitschke M, Berry GJ, Brazelton T, Shorthouse R, Huang X, Boname J, Girgis R, Raitz BA, Mocarski E, Sandford G, Morris RE.

J Heart Lung Transplant. 1998 May;17(5):439-51.

PMID:
9628562
24.

Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus.

Stoddart CA, Cardin RD, Boname JM, Manning WC, Abenes GB, Mocarski ES.

J Virol. 1994 Oct;68(10):6243-53.

25.
26.

Changing attitudes create health care dilemma.

Boname JR.

AORN J. 1975 Oct;22(4):543-8. No abstract available.

PMID:
812420
27.

Carbon dioxide insufflation following culdoscopy.

Boname JR.

Anesth Analg. 1968 Jan-Feb;47(1):87-8. No abstract available.

PMID:
5688868
28.

The acute treatment of heat stroke.

Boname JR, Wilhite WC Jr.

South Med J. 1967 Aug;60(8):885-7. Review. No abstract available.

PMID:
5341065
29.

Oxygen concentrations in closed-circle cyclopropane anesthesia.

Boname JR.

Anesth Analg. 1967 Mar-Apr;46(2):235-42. No abstract available.

PMID:
5335725
30.

An eye toward recovery with combined anesthesia.

Boname JR.

Anesth Analg. 1965 Nov-Dec;44(6):762-8. No abstract available.

PMID:
5891906
31.

A retinal excitation gradient in a uniform area of stimulation.

KRUGER L, BONAME JR.

J Exp Psychol. 1955 Mar;49(3):220-4. No abstract available.

PMID:
14367700

Supplemental Content

Loading ...
Support Center